American Health Research Institute

Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD

Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson et al. · CHEST Journal · 2016 · 102 citations

Pulmonary Care, Advanced Lung Disease, Pulmonary Medicine +3

Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

Claus Vogelmeier, C. Verkindre, D. Cheung et al. · Pulmonary Pharmacology & Therapeutics · 2010 · 57 citations

Molecular Pharmacology, Medicine, Pulmonary Pharmacology +7

Pediatric Thyroid Carcinoma Incidence and Temporal Trends in the USA (1973–2007): Race or Shifting Diagnostic Paradigm?

Laurens Holmes, Jobayer Hossain, Franklin Opara · ISRN Oncology · 2012 · 55 citations · Full text

Racial/Ethnic Variability in Hypertension Prevalence and Risk Factors in National Health Interview Survey

Laurens Holmes, Jobayer Hossain, Doriel Ward et al. · ISRN Hypertension · 2012 · 34 citations · Full text

Ethnicity, Racial/ethnic Variability, Hypertension +23

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

Colin Reisner, Leonardo M. Fabbri, Edward Kerwin et al. · Respiratory Research · 2017 · 24 citations · Full text